يعرض 1 - 10 نتائج من 440 نتيجة بحث عن '"McCoy, Kathy D"', وقت الاستعلام: 1.28s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: University of Montreal Research Center (CRCHUM), Montreal, QC H2X 0A9, Canada, Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 3E4, Melanoma Research Alliance, 730 15th Street NW, Washington, DC 20005, Seerave Foundation, The Seerave Foundation, 35-37 New Street, St Helier, JE2 3RA Jersey, Oncology Discovery Research, AbbVie Inc, North Chicago, IL 60064, Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ 08854, Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, MaaT Pharma, 69007 Lyon, Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO 80045, Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, Gustave Roussy Cancer Center, ClinicoBiome, 94805 Villejuif, France, Université Paris Saclay, Faculty of Medicine, 94270 Kremlin Bicêtre, Departments of Immunology & Microbiology and Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, University of Groningen Groningen, Bio-Me, 0349 Oslo, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Department of Physiology & Pharmacology, Snyder Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada, Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA, Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA USA, Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA, Sanford Burnham Prebys Discovery Medical Research Institute, La Jolla, CA 92037, USA, Weizmann Institute of Science, Computer Science and Applied Mathematics Department, 234th Herzel st., Rehovot 7610001, Israel, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA, Micronoma Inc., San Diego, CA 92121, USA, Johns Hopkins School of Medicine, Department of Oncology, Baltimore, MD 21287, USA, Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, Department of Molecular Biology and Biochemistry, University of California, Irvine Irvine, CA 92697-2025, USA, Department of Biochemistry and Microbiology, New Jersey Institute of Food, Nutrition and Health, Rutgers University, New Brunswick, NY 08901, Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA, Gustave Roussy Cancer Center, ClinicoBiome, 94805 Villejuif, GK is supported by the Ligue contre le Cancer (équipe labellisée), Agence National de la Recherche (ANR-22-CE14-0066 VIVORUSH, ANR-23-CE44-0030 COPPERMAC, ANR-23-R4HC-0006 Ener-LIGHT), Association pour la recherche sur le cancer (ARC), Cancéropôle Ile-de-France, Fondation pour la Recherche Médicale (FRM), a donation by Elior, European Joint Programme on Rare Diseases (EJPRD) Wilsonmed, European Research Council Advanced Investigator Award (ERC-2021-ADG, Grant No. 101052444, project acronym: ICD-Cancer, project title: Immunogenic cell death (ICD) in the cancer-immune dialogue), The ERA4 Health Cardinoff Grant Ener-LIGHT, European Union Horizon 2020 research and innovation programmes Oncobiome (grant agreement number: 825410, Project Acronym: ONCOBIOME, Project title: Gut OncoMicrobiome Signatures GOMS associated with cancer incidence, prognosis and prediction of treatment response, Prevalung (grant agreement number 101095604, Project Acronym: PREVALUNG EU, project title: Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception), Neutrocure (grant agreement number 861878 : Project Acronym: Neutrocure, project title: Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation), National support managed by the Agence Nationale de la Recherche under the France 2030 programme (reference number 21-ESRE-0028, ESR/Equipex+ Onco-Pheno-Screen), Hevolution Network on Senescence in Aging (reference HF-E Einstein Network), Institut National du Cancer (INCa), Institut Universitaire de France, LabEx Immuno-Oncology ANR-18-IDEX-0001, a Cancer Research ASPIRE Award from the Mark Foundation, PAIR-Obésité INCa_1873, the RHUs Immunolife and LUCA-pi (ANR-21-RHUS-0017 and ANR-23-RHUS-0010, both dedicated to France Relance 2030), Seerave Foundation, SIRIC Cancer Research and Personalized Medicine (CARPEM, SIRIC CARPEM INCa-DGOS-Inserm-ITMO Cancer_18006 supported by Institut National du Cancer, Ministère des Solidarités et de la Santé and INSERM). This study contributes to the IdEx Université de Paris Cité ANR-18-IDEX-0001., ANR-18-IDEX-0001,Université de Paris,Université de Paris(2018), ANR-21-ESRE-0028,ONCO-PHENO-SCREEN,Next-generation phenotypic screening for oncological applications(2021), ANR-21-RHUS-0017,IMMUNOLIFE,Microbiota-centered interventions to solve antibiotics-induced primary resistance to immune checkpoint inhibitors(2021), ANR-23-RHUS-0010,LUCA-pi,Lung cancer prevention and interception(2023), European Project: 825410, H2020-EU.3.1., H2020-EU.3.1.2.,ONCOBIOME (2019), European Project: 320339,EC:FP7:ERC,ERC-2012-ADG_20120314,IMMUNODEATH(2013)

    المصدر: ISSN: 1535-6108 ; Cancer Cell ; https://hal.science/hal-04599809Test ; Cancer Cell, 2024, 42 (1), pp.16-34. ⟨10.1016/j.ccell.2023.12.003⟩.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38157864; info:eu-repo/grantAgreement//825410/EU/Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response./ONCOBIOME; info:eu-repo/grantAgreement/EC/FP7/320339/EU/Immunogenic cell death in anticancer therapy/IMMUNODEATH; hal-04599809; https://hal.science/hal-04599809Test; https://hal.science/hal-04599809/documentTest; https://hal.science/hal-04599809/file/nihms-1990346.pdfTest; PUBMED: 38157864

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: Sinnberg, Tobias; Lichtensteiger, Christa; Hasan Ali, Omar; Pop, Oltin T; Jochum, Ann-Kristin; Risch, Lorenz; Brugger, Silvio D; Velic, Ana; Bomze, David; Kohler, Philipp; Vernazza, Pietro; Albrich, Werner C; Kahlert, Christian R; Abdou, Maire-Therese; Wyss, Nina; Hofmeister, Kathrin; Niessner, Heike; Zinner, Carl; Gilardi, Mara; Tzankov, Alexandar; . (2023). Pulmonary Surfactant Proteins are Inhibited by IgA Autoantibodies in Severe COVID-19. American journal of respiratory and critical care medicine, 207(1), pp. 38-49. American Lung Association 10.1164/rccm.202201-0011OC

    مصطلحات موضوعية: 610 Medicine & health

    وصف الملف: application/pdf

  4. 4
    دورية أكاديمية

    المساهمون: Gouvernement du Canada | Canadian Institutes of Health Research, Canadian Foundation for Innovation JR Evans Leaders Fund (reference number 40697) Peter Lougheed Foundation. Alberta Health Services Critical Care Strategic Clinical Network.

    المصدر: Nature Medicine ; volume 29, issue 4, page 1017-1027 ; ISSN 1078-8956 1546-170X

  5. 5
    دورية أكاديمية

    المساهمون: Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada, Alberta Innovates | Alberta Innovates - Health Solutions, Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada, Gouvernement du Canada | Canadian Institutes of Health Research

    المصدر: Nature Communications ; volume 14, issue 1 ; ISSN 2041-1723

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المؤلفون: Franco, Fabien, McCoy, Kathy D.

    المصدر: Science ; volume 384, issue 6694, page 384-385 ; ISSN 0036-8075 1095-9203

  8. 8
    دورية أكاديمية

    المساهمون: Lomonaco, Tommaso, Natural Sciences and Engineering Council of Canada, Alberta Innovates, International Microbiome Centre, IMPACTT Microbiome Research Core, Canada Foundation for Innovation

    المصدر: PLOS ONE ; volume 17, issue 4, page e0267093 ; ISSN 1932-6203

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية